Skip to main content
Molecular Cancer logoLink to Molecular Cancer
. 2022 Sep 29;21:188. doi: 10.1186/s12943-022-01660-3

Retraction Note to: Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway

Mingjun Yu 1,2,3, Yixue Xue 4,5,6, Jian Zheng 1,2,3, Xiaobai Liu 1,2,3, Hai Yu 1,2,3, Libo Liu 4,5,6, Zhen Li 1,2,3, Yunhui Liu 1,2,3,
PMCID: PMC9523928  PMID: 36175912

Retraction note to: Mol Cancer 16, 110 (2017)

10.1186/s12943-017-0677-9.

The Editor-in-Chief has retracted this article. After publication, concerns were raised regarding partial image overlap in Figs.1, 2 and 5–7. The Editor-in-Chief therefore no longer has confidence in the presented data.

Yunhui Liu has stated on behalf of all co-authors that they do not agree to this retraction.

Footnotes

The online version of the original article can be found at 10.1186/s12943-017-0677-9.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Molecular Cancer are provided here courtesy of BMC

RESOURCES